TCL Archive BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women November 3, 1978
TCL Archive In Brief: Bernard Fisher Professorship Endowed By ICI Pharma; Brady wins RSNA Medal January 12, 1990
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
